glp 1 drugs and thyroid cancer Does GLP-1 drug affect risk? There is no conclusive evidence

4,5 TABLE 1 provides a summary of key characteristics of currently available injectable GLP-1 receptor agonists

In sub-populations with pre-diabetes, Tao et al

In a large Swedish study published in JAMA Psychiatry in November 2024, scientists found that people who were taking the GLP-1 drugs semaglutide or liraglutide were less likely to be hospitalized for AUD

Diabetes Care 46 , 801810 (2023)

If we have done the work and nausea is still limiting treatment, switching between Wegovy and Zepbound, or to Foundayo (the oral GLP-1), is a real option

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases